ZS Associates Office Managing Director Ranjini Cassup (front) and Global Executive Dharmendra Sahay cut the ribbon at the official opening of the company's new Kingston on Wednesday, February 5.

In a report released yesterday, Matthew Hedberg from RBC Capital maintained a Buy rating on Zscaler (ZS – Research Report), with a price target of $230.00. The company’s shares closed ...

Facing a world of new beginnings and constant change, ZS Associates had a big story to tell about the future of healthcare – but they were under the radar of the executive change makers who could make ...

As host of her own podcast with ZS on patient centricity, she is the perfect guest to dissect the topic. The editorial staff had no role in this post's creation. Pharma ...

ZS Associates, United States of America (USA) Time frame: 1 May 2023 - 30 April 2024 Research. Overall research output. Count ...

ZS Associates - India, India Time frame: 1 May 2023 - 30 April 2024 Research. Overall research output. Count ...

ZS Associates is transforming global healthcare by driving toward a connected ecosystem. We leverage the power of data, science, and technology to make more intelligent healthcare decisions and ...

Investors in Zscaler Inc (Symbol: ZS) saw new options become available today, for the March 2023 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

ZS recently published results from research on the State of KAM in Pharma. When we asked KAM executives to identify investment priorities from our 16-point KAM360TM framework of key drivers of KAM ...

In-person meetings between customers and salespeople were once at the heart of B2B buying and selling. Now digital communication is embedding itself in every aspect of business.